Mufg Americas Holdings Corp Astrazeneca PLC Transaction History

Mufg Americas Holdings Corp

$0
Q3 2023

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Dec 01, 2022	SELL	$59.26 - $71.14 $37,926 - $45,529	-640 Reduced 68.09%	300 $20,000
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $37,926 - $45,529	-640 Reduced 68.09%	300 $20,000
Q2 2021 Dec 01, 2022	SELL	$48.42 - $60.18 $43,093 - $53,560	-890 Reduced 48.63%	940 $56,000
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $43,093 - $53,560	-890 Reduced 48.63%	940 $56,000
Q4 2020 Dec 01, 2022	SELL	$48.52 - $58.02 $222,706 - $266,311	-4,590 Reduced 71.5%	1,830 $91,000
Q4 2020 Feb 03, 2021	SELL	$48.52 - $58.02 $222,706 - $266,311	-4,590 Reduced 71.5%	1,830 $91,000
Q3 2020 Dec 01, 2022	BUY	$53.07 - $61.1 $29,984 - $34,521	565 Added 9.65%	6,420 $352,000
Q3 2020 Nov 03, 2020	BUY	$53.07 - $61.1 $29,984 - $34,521	565 Added 9.65%	6,420 $352,000
Q2 2020 Dec 01, 2022	BUY	$43.1 - $55.31 $239,420 - $307,247	5,555 Added 1851.67%	5,855 $310,000
Q2 2020 Aug 06, 2020	SELL	$43.1 - $55.31 $14,007 - $17,975	-325 Reduced 5.26%	5,855 $310,000
Q1 2020 Apr 24, 2020	SELL	$37.79 - $51.33 $11,337 - $15,399	-300 Reduced 4.63%	6,180 $276,000
Q4 2019 Feb 10, 2020	SELL	$42.46 - $50.46 $4,246 - $5,046	-100 Reduced 1.52%	6,480 $323,000
Q3 2019 Nov 06, 2019	BUY	$40.12 - $45.47 $13,761 - $15,596	343 Added 5.5%	6,580 $293,000
Q2 2019 Aug 09, 2019	SELL	$37.28 - $41.68 $708 - $791	-19 Reduced 0.3%	6,237 $257,000
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $379,813 - $460,400	-10,702 Reduced 63.11%	6,256 $253,000
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $406,123 - $457,136	11,018 Added 185.49%	16,958 $644,000
Q1 2018 May 07, 2018	SELL	$32.97 - $36.63 $6,198 - $6,886	-188 Reduced 3.07%	5,940 $208,000
Q4 2017 Feb 08, 2018	BUY	$32.09 - $34.78 $6,032 - $6,538	188 Added 3.16%	6,128 $0
Q2 2017 Aug 07, 2017	BUY	N/A	5,940	5,940 $0

Others Institutions Holding AZN

# of Institutions

1,334

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.42 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.95 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.62 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.59 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.34 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Account